To get the latest experience from our website, please upgrade your browser.
Johnson & Johnson’s Janssen Pharmaceuticals division announced the U.S. Food and Drug Administration approved its latest Type 2 diabetes drug, Invokamet XR (canagliflozin and metformin extended release). Meanwhile, Invokana lawsuit [...]
In the last few weeks, the U.S. Food and Drug Administration tackled a number of drug and device warnings and recalls. These include prescription opioid products, the Vascu-Guard patch used [...]
The U.S. Food and Drug Administration has approved Bayer’s postmarket surveillance study plan for Essure — a permanent birth-control device linked to serious adverse events and deaths. The FDA orders [...]
Use of power morcellators dropped significantly after the U.S. Food and Drug Administration warned they could spread cancer, according to a new study. Supporters of the devices said complication rates [...]
Portola Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) did not approve its antidote for uncontrolled bleeding linked to blood thinners including Xarelto (rivaroxaban) and Eliquis (apixaban). The [...]
On July 26, the U.S. Food and Drug Administration approved changes to the labels of fluoroquinolone antibiotics including, Levaquin (levofloxacin), Cipro (ciprofloxacin), Avelox (moxifloxacin) and Factive (gemifloxacin). According to the [...]